Dr. Vinni Juneja, MD
- Medicare services, 2024
- 183,310
- Medicare patients, 2024
- 699
- Part D claims, 2024
- 1,090
- Clinical trials
- 1
- MIPS score, 2024
- 97
- Practice address
- 11886 Healing Way, Silver Spring, MD 20904
- Practice phone
- Call (301) 933-3216
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Maryland Oncology Hematology, PA
Silver Spring, Maryland
Find Dr. Juneja's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Vinni Juneja is a hematologist and oncologist in Silver Spring, Maryland
Dr. Juneja practices at Maryland Oncology Hematology, PA in Silver Spring, Maryland.
Dr. Juneja's NPI, 1639223522, was assigned on January 22, 2007. Dr. Juneja holds Virginia license 0101240280.
- NPI
- 1639223522NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9133228919
- NPI enumeration date
- January 22, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (301) 933-3216
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Vinni Juneja practices at Maryland Oncology Hematology, PA in Silver Spring, Maryland
Dr. Juneja's primary practice is Maryland Oncology Hematology, PA, at 11886 Healing Way, Silver Spring, MD 20904 in Montgomery County. The practice phone is (301) 933-3216.
- Maryland Oncology Hematology, PA11886 Healing Way, Silver Spring, MD 20904 · Montgomery CountyPhone(301) 933-3216
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Vinni Juneja is affiliated with 6 sites of care and 3 medical groups
Dr. Juneja's primary practice is Maryland Oncology Hematology, PA in Silver Spring, Maryland. Dr. Juneja is also affiliated with Holy Cross Hospital. The medical group on file is Maryland Oncology Hematology. Dmand AI also links Dr. Juneja to 1 more hospital, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Vinni Juneja's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Juneja practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Maryland Oncology Hematology, PA | Available with a free account |
| +5 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Vinni Juneja is one of 245 hematologists and oncologists in Maryland
Hematology and oncology is Dr. Juneja's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Juneja is licensed in Virginia.
Specialties and state licenses
- Hematology and oncology, VirginiaPrimary
Hematologists and oncologists near Dr. Juneja
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Vinni Juneja billed Medicare for 183,310 services in 2024
CMS data shows 183,310 Medicare services from Dr. Juneja across 62 procedure codes in 2024, for 699 Medicare patients. Medicare paid $1,705,630 for them.
Dr. Juneja's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 110,4922024: 162,74347%
- Other services
- 2023: 12,7502024: 12,9001%
- Lab and pathology
- 2023: 3,4692024: 3,94414%
- Tests and treatments
- 2023: 1,8572024: 2,34226%
- Office and hospital visits
- 2023: 1,1022024: 1,23312%
- Surgery
- 2023: 4502024: 14867%
Where Dr. Juneja's Medicare services took place, 2024
- In an office183,252100%
- In a facility580%
Dr. Juneja compared with the Maryland median for hematologists and oncologists, 2024
- Dr. Juneja
- Maryland median
- Medicare services
- 183,310vs 1,88497.3 times
- Medicare patients
- 699vs 39677% above
- Part D claims
- 764vs 38399% above
Medians across 205 hematologists and oncologists in Maryland with Dmand AI profiles that report each measure.
Dr. Juneja's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Juneja?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Juneja and other hematologists and oncologists in Maryland.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Vinni Juneja treated 699 Medicare patients in 2024, average age 76
CMS counts 699 Medicare patients who saw Dr. Juneja in 2024. The largest group is 65 to 74, with 259 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Juneja's median patient age at 60, with 67% women.
Dr. Juneja's Medicare patients by age, 2024
Dr. Juneja's Medicare patients by sex, 2024
- Women43062%
- Men26938%
Chronic conditions among Dr. Juneja's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis46%
- Diabetes42%
- Cancer40%
- Chronic kidney disease39%
- Ischemic heart disease30%
- Mood disorders23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Juneja's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 60
Patient panel by sex, all payers
- Women67%
- Men29%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Vinni Juneja wrote 1,090 Medicare Part D claims in 2024
In 2024, Dr. Juneja wrote 1,090 Medicare Part D claims for 174 patients. 66% of them were for generic drugs. CMS names the drug for 764 of them, across 30 drugs with 11 or more claims each, at $1,690,203 in total drug cost. In 2023, CMS named 426 claims across 20 drugs.
Dr. Juneja's Part D claims by kind of drug, 2024
- Generic714 claims66%
- Brand-name and other376 claims34%
Dr. Juneja's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Juneja's Part D claims, 2024
- Opioids9%101 of 1,090 claims
- Antibiotics4%39 of 1,090 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4262024: 76479%
Drugs named by CMS: 30 in 2024, 20 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Vinni Juneja scored 97 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Juneja for performance year 2024, reported individually. Dr. Juneja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Juneja as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Juneja's MIPS scores, performance year 2024
- 97of 100Final score
- 81.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Vinni Juneja has worked on 1 clinical trial
Dmand AI links Dr. Juneja to 1 clinical trial. Conditions studied include Carcinoma, Transitional Cell and Urinary Bladder Neoplasms.
Conditions in Dr. Juneja's trials
- Carcinoma, Transitional Cell
- Urinary Bladder Neoplasms
Investigators on the most trials with Dr. Juneja
- Bruce B. Bank, MD1 shared trial
- Rafael Barrera, MD1 shared trial
- David Berz, MD, MPH, PhD1 shared trial
Recent clinical trials with Dr. Juneja
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Vinni Juneja received $42,675 in industry payments from 2016 to 2025
CMS Open Payments shows 1,003 general payments to Dr. Juneja from 85 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Celgene Corporation paid the most, $6,160.
General payments to Dr. Juneja by program year, 2016 to 2025
General payments to Dr. Juneja by kind, 2016 to 2025
- Food and beverage$21,24350%
- Consulting fees$15,59437%
- Honoraria$2,0005%
- Travel and lodging$1,9485%
- Other$1,8904%
Companies that paid Dr. Juneja the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Vinni Juneja's profile data
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Vinni Juneja
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Vinni Juneja's NPI number?
Dr. Vinni Juneja's NPI number is 1639223522. It was assigned on January 22, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Vinni Juneja?
Dr. Vinni Juneja is a hematologist and oncologist in Silver Spring, Maryland. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Vinni Juneja practice?
Dr. Juneja practices at 11886 Healing Way, Silver Spring, MD 20904. Dr. Juneja's primary practice is Maryland Oncology Hematology, PA in Silver Spring, Maryland. Dmand AI also links Dr. Juneja to 1 hospital, 2 group practices and clinics, 2 medical groups and 1 home health agency.
What is Dr. Vinni Juneja's office phone number?
The practice phone on file for Dr. Juneja is (301) 933-3216.
What is Dr. Vinni Juneja's medical license number?
Dr. Juneja holds Virginia license 0101240280.
Which hospitals is Dr. Vinni Juneja affiliated with?
Dr. Juneja is affiliated with Holy Cross Hospital. Dmand AI links Dr. Juneja to 1 more hospital.
What medical group is Dr. Vinni Juneja part of?
Dr. Juneja is linked to Maryland Oncology Hematology. Dmand AI links Dr. Juneja to 2 more medical groups.
Does Dr. Vinni Juneja accept Medicare?
Yes. CMS data shows Dr. Juneja billed Medicare for 183,310 services in 2024, and Dr. Juneja accepts Medicare assignment.
Does Dr. Vinni Juneja offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Juneja as offering telehealth services.
What is Dr. Vinni Juneja's MIPS score?
Dr. Juneja's MIPS final score for performance year 2024 is 97 out of 100, reported individually.
Show 6 more questionsShow fewer questions
How many Medicare patients does Dr. Vinni Juneja see?
CMS counts 699 Medicare patients who saw Dr. Juneja in 2024, with an average age of 76.
What services does Dr. Vinni Juneja bill to Medicare?
In 2024, Dr. Juneja's most billed Medicare services were injected or infused drug (J1439), injected or infused drug (J0881) and injected or infused drug (J9263).
What drugs does Dr. Vinni Juneja prescribe most?
In 2024 Medicare Part D data, Dr. Juneja's most prescribed drugs by claims were Eliquis, Anastrozole and Prednisone.
Has Dr. Vinni Juneja received payments from drug or device companies?
CMS Open Payments shows $42,675 in general payments to Dr. Juneja from 85 companies from 2016 to 2025. The largest total came from Celgene Corporation.
How long has Dr. Vinni Juneja been practicing?
Dr. Juneja graduated from medical school in 2000, 26 years ago.
Does Dr. Vinni Juneja do research?
Dr. Juneja has worked on 1 clinical trial.
Selling to hematology and oncology practices?
See hematologists and oncologists in Maryland by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card